[Hormonal contraceptives].
Many changes occurred in hormonal contraceptives in the past few years to improve benefice/risks balance and get a better tolerance and observance. These changes concerned the decrease of steroids doses, changes in estroprogestogen sequence, use of less androgenic progestogen and more recently the use of new ways of administration with transdermal system, vaginal ring or subdermal contraceptive implant to avoid daily use. This article makes a review of hormonal contraceptives available in France and benefits of recent innovations.
Carlotti
Nathalie
N
natcarlotti@wanadoo.fr
D003271:Contraceptive Agents, Female; D003274:Contraceptive Devices, Female; D003278:Contraceptives, Oral, Hormonal / Q000008:administration & dosage* / Q000009:adverse effects*; D004304:Dosage Forms; D004333:Drug Administration Routes; D004967:Estrogens / Q000008:administration & dosage / Q000009:adverse effects; D005260:Female; D005602:France; D006801:Humans; D011372:Progestins / Q000008:administration & dosage / Q000009:adverse effects; D018570:Risk Assessment
D003271:Contraceptive Agents, Female; D003278:Contraceptives, Oral, Hormonal; D004304:Dosage Forms; D004967:Estrogens; D011372:Progestins